Euroapi France
1 more in force is now held by another company
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
1
Ending by 2030
Dec 2027
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Dec 4, 2026The maintenance fee for Whole-Cell System For Cytochrome P450 Monooxygenases Biocatalysis (US 10,308,972) comes due Dec 4, 2026. Unpaid by Jun 4, 2027, it lapses early.
- 1 fee due Feb 20, 2027The maintenance fee for 21-Hydroxylation of Steroids (US 10,385,376) comes due Feb 20, 2027. Unpaid by Aug 20, 2027, it lapses early.
- 1 fee due Mar 3, 2027The maintenance fee for Genetically Transformed Yeasts Capable of Producing a Molecule of Interest at a High Titre (US 10,400,261) comes due Mar 3, 2027. Unpaid by Sep 3, 2027, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 10 of 10
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,211,676 | Cholesterol-Producing Yeast Strains and Uses Thereof In force · High confidence | In force | High confidence | |
| US 10,400,261 | Genetically Transformed Yeasts Capable of Producing a Molecule of Interest at a High Titre In force · Medium confidence | In force | Medium confidence | |
| US 9,994,888 | Process for Preparing Genetically Transformed Yeasts Capable of Producing a Molecule of Interest at a High Titre In force · High confidence | In force | High confidence | |
| US 10,308,972 | Whole-Cell System For Cytochrome P450 Monooxygenases Biocatalysis In force · High confidence | In force | High confidence | |
| US 9,783,569 | Method for Preparing 6-Alkylated Steroidal Derivatives and Corresponding Alkylated 5,6,7,8-Tetrahydronaphthalene-2(4 Alpha.h)-Ones In force · High confidence | In force | High confidence | |
| US 10,155,934 | Novel Cytochrome P450 Polypeptide with Increased Enzyme Activity In force · Medium confidence | In force | Medium confidence | |
| US 9,765,307 | Novel Cytochrome P450 Polypeptide with Increased Enzyme Activity In force · High confidence | In force | High confidence | |
| US 10,385,376 | 21-Hydroxylation of Steroids In force · High confidence | In force | High confidence | |
| US 11,608,514 | 21-Hydroxylation of Steroids In force · Medium confidence | In force | Medium confidence | |
| US 12,630,853 | Biotechnological Optimization of Microorganisms for the 1,2-Dehydrogenation of Steroids In force · High confidence | In force | High confidence |
Also on record, not counted in the 10: 1 patent in force now held by others · 1 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.